Insider transactions

EDGAR

HEPION PHARMACEUTICALS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
12 transactions, 26,700,000 shares
Sum of shares × price per share: 1,235,000
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–36 of 36

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-23 Filed 2026-10-27LoPriore Chase Director · Officer: VP, Corp. Dev.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (1,530,000) — exercise price 0.14
Acquired (A)1,530,0000—2,875,500Direct (D) No
F1
  • F1 127,500 options vest in equal amounts monthly over 12 months from date of grant.
Open filing 0001493152-26-048704 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Liddy James Gordon Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (510,000) — exercise price 0.14
Acquired (A)510,0000—809,000Direct (D) No
F1
  • F1 42,500 options vest in equal amounts monthly over 12 months from date of grant.
Open filing 0001493152-26-048710 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Stetz Gary S. II Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (510,000) — exercise price 0.14
Acquired (A)510,0000—809,000Direct (D) No
F1
  • F1 42,500 options vest in equal amounts monthly over 12 months from date of grant.
Open filing 0001493152-26-048703 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Appajosyula Sireesh Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (1,530,000) — exercise price 0.14
Acquired (A)1,530,0000—2,875,500Direct (D) No
F1
  • F1 127,500 options vest in equal amounts monthly over 12 months from date of grant.
Open filing 0001493152-26-048705 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Stetz Gary S. Director · Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (1,530,000) — exercise price 0.14
Acquired (A)1,530,0000—2,875,500Direct (D) No
F1
  • F1 127,500 options vest in equal amounts monthly over 12 months from date of grant.
Open filing 0001493152-26-048708 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Purcell Michael J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (510,000) — exercise price 0.14
Acquired (A)510,0000—809,000Direct (D) No
F1
  • F1 42,500 options vest in equal amounts monthly over 12 months from date of grant.
Open filing 0001493152-26-048706 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27LoPriore Vincent S Director · Officer: Executive Chairman
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (1,530,000) — exercise price 0.14
Acquired (A)1,530,0000—2,875,500Direct (D) No
F1
  • F1 127,500 options vest in equal amounts monthly over 12 months from date of grant.
Open filing 0001493152-26-048707 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Fisher Danina Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (510,000) — exercise price 0.14
Acquired (A)510,0000—809,000Direct (D) No
F1
  • F1 42,500 options vest in equal amounts monthly over 12 months from date of grant.
Open filing 0001493152-26-048709 Read from the filing’s XML Dispute this row
2026-09-29 Filed 2026-10-02Fisher Danina Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)200,0000.05
10,000

Derived: shares × price per share. Exact value 10000.00.

200,000Direct (D) No— Open filing 0001493152-26-045526 Read from the filing’s XML Dispute this row
2026-09-29 Filed 2026-10-02Fisher Danina Director
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants — underlying Commmon Stock (200,000) — exercise price 0.06
Acquired (A)200,0000—200,000Direct (D) No— Open filing 0001493152-26-045526 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-14LoPriore Vincent S Director · Officer: Executive Chairman
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants — underlying Common Stock (12,500,000) — exercise price 0.06
Acquired (A)12,500,0000—22,500,000Indirect (I) By Gravitas Capital LPNo
F1, F2
  • F1 Warrant is only exercisable upon stockholder approval of an increase in the authorized shares of the Company's Common Stock.
  • F2 Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.
Open filing 0001493152-26-042470 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-09-10Purcell Michael J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (299,000) — exercise price 0.08
Acquired (A)299,0000—299,000Direct (D) No— Open filing 0001493152-26-042169 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Fisher Danina Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (299,000) — exercise price 0.08
Acquired (A)299,0000—299,000Direct (D) No— Open filing 0001493152-26-039698 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Stetz Gary S. II Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (299,000) — exercise price 0.08
Acquired (A)299,0000—299,000Direct (D) No— Open filing 0001493152-26-039685 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Liddy James Gordon Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (299,000) — exercise price 0.08
Acquired (A)299,0000—299,000Direct (D) No— Open filing 0001493152-26-039690 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Stetz Gary S. Director · Officer: Interim CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (1,345,500) — exercise price 0.08
Acquired (A)1,345,5000—1,345,500Direct (D) No
F1
  • F1 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.
Open filing 0001493152-26-039705 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Appajosyula Sireesh Director · Officer: Chief Operating Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (1,345,500) — exercise price 0.08
Acquired (A)1,345,5000—1,345,500Direct (D) No
F1
  • F1 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.
Open filing 0001493152-26-039688 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21LoPriore Chase Director · Officer: VP, Corp. Dev.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (1,345,500) — exercise price 0.08
Acquired (A)1,345,5000—1,345,500Direct (D) No
F1
  • F1 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.
Open filing 0001493152-26-039701 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21LoPriore Vincent S Director · Officer: Executive Chairman
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options — underlying Common Stock (1,345,500) — exercise price 0.08
Acquired (A)1,345,5000—1,345,500Direct (D) No
F1
  • F1 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.
Open filing 0001493152-26-039702 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12Stetz Gary S. Director · Officer: Interim CEO
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,000,0000.05
100,000

Derived: shares × price per share. Exact value 100000.00.

3,250,000Direct (D) No— Open filing 0001493152-26-037496 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12Stetz Gary S. Director · Officer: Interim CEO
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants — underlying Common Stock (2,000,000) — exercise price 0.06
Acquired (A)2,000,0000—2,000,000Direct (D) No— Open filing 0001493152-26-037496 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12Stetz Gary S. II Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)500,0000.05
25,000

Derived: shares × price per share. Exact value 25000.00.

500,000Direct (D) No— Open filing 0001493152-26-037500 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12Stetz Gary S. II Director
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants — underlying Common Stock (500,000) — exercise price 0.06
Acquired (A)500,0000—500,000Direct (D) No— Open filing 0001493152-26-037500 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12LoPriore Vincent S Director · Officer: Executive Chairman
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)8,000,0000.05
400,000

Derived: shares × price per share. Exact value 400000.00.

14,250,000Indirect (I) By Gravitas Capital LPNo
F1
  • F1 Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.
Open filing 0001493152-26-037489 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12LoPriore Vincent S Director · Officer: Executive Chairman
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,000,0000.05
100,000

Derived: shares × price per share. Exact value 100000.00.

16,250,000Indirect (I) By Invictus Capital Advisors Pension PlanNo
F2
  • F2 Mr. LoPriore is the trustee and beneficiary of the Invictus Capital Advisors Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity.
Open filing 0001493152-26-037489 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12LoPriore Vincent S Director · Officer: Executive Chairman
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants — underlying Common Stock (8,000,000) — exercise price 0.06
Acquired (A)8,000,0000—8,000,000Indirect (I) By Gravitas Capital LPNo
F1
  • F1 Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.
Open filing 0001493152-26-037489 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12LoPriore Vincent S Director · Officer: Executive Chairman
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants — underlying Common Stock (2,000,000) — exercise price 0.06
Acquired (A)2,000,0000—10,000,000Indirect (I) By Invictus Capital Advisors Pension PlanNo
F2
  • F2 Mr. LoPriore is the trustee and beneficiary of the Invictus Capital Advisors Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity.
Open filing 0001493152-26-037489 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12Purcell Michael J. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,000,0000.05
100,000

Derived: shares × price per share. Exact value 100000.00.

3,250,000Direct (D) No— Open filing 0001493152-26-037493 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12Purcell Michael J. Director
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants — underlying Common Stock (2,000,000) — exercise price 0.06
Acquired (A)2,000,0000—2,000,000Direct (D) No— Open filing 0001493152-26-037493 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12Appajosyula Sireesh Director · Officer: Chief Operating Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,000,0000.05
100,000

Derived: shares × price per share. Exact value 100000.00.

3,250,000Direct (D) No— Open filing 0001493152-26-037490 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-12Appajosyula Sireesh Director · Officer: Chief Operating Officer
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants — underlying Common Stock (2,000,000) — exercise price 0.06
Acquired (A)2,000,0000—2,000,000Direct (D) No— Open filing 0001493152-26-037490 Read from the filing’s XML Dispute this row
2026-04-21 Filed 2026-04-27Purcell Michael J. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock, par value $0.0001 per share
Acquired (A)1,250,0000.04
50,000

Derived: shares × price per share. Exact value 50000.00.

1,250,000Direct (D) No— Open filing 0001493152-26-019202 Read from the filing’s XML Dispute this row
2026-04-21 Filed 2026-04-27Appajosyula Sireesh Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock, par value $0.0001 per share
Acquired (A)1,250,0000.04
50,000

Derived: shares × price per share. Exact value 50000.00.

1,250,000Direct (D) No— Open filing 0001493152-26-019028 Read from the filing’s XML Dispute this row
2026-04-21 Filed 2026-04-27Stetz Gary S. Director · Officer: Interim CEO
P

Open market or private purchase of non-derivative or derivative security

Common Stock, par value $0.0001 per share
Acquired (A)1,250,0000.04
50,000

Derived: shares × price per share. Exact value 50000.00.

1,250,000Indirect (I) See FootnoteNo
F1
  • F1 Through Stetz Belgiovine CPA 401K F/B/O Gary S. Stetz
Open filing 0001493152-26-019027 Read from the filing’s XML Dispute this row
2026-04-21 Filed 2026-04-27LoPriore Vincent S Director · Officer: Executive Chairman · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock, par value $0.0001 per share
Acquired (A)5,000,0000.04
200,000

Derived: shares × price per share. Exact value 200000.00.

5,000,000Indirect (I) By Gravitas Capital LPNo
F1
  • F1 Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.
Open filing 0001493152-26-019029 Read from the filing’s XML Dispute this row
2026-04-21 Filed 2026-04-27LoPriore Vincent S Director · Officer: Executive Chairman · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock, par value $0.0001 per share
Acquired (A)1,250,0000.04
50,000

Derived: shares × price per share. Exact value 50000.00.

6,250,000Indirect (I) By Invictus Capital Advisors Pension PlanNo
F2
  • F2 Mr. LoPriore is the trustee and beneficiary of the Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity.
Open filing 0001493152-26-019029 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–1 of 1

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Ancora Advisors LLC Partly reported under another manager1 SH0 dollarsUnchanged Prior quarter: 1Open filing 0001446114-26-000020 Filed 2026-11-17 Dispute this row
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Kenneth Rickel Common Stock, par value $0.0001 per share7.27,250,000.0010/20/2026 Filed 2026-10-21SCHEDULE 13G/AAmendment 1Open filing 0001493152-26-047920 Dispute this row
Gravitas Collective Corp. Common Stock, par value $0.0001 per share19.925,000,000.0010/06/2026 Filed 2026-10-26SCHEDULE 13DOpen filing 0001493152-26-048601 Dispute this row
KI Holdings Ltd. Common Stock, par value $0.0001 per share10.210,000,000.0008/03/2026 Filed 2026-09-16SCHEDULE 13D/AAmendment 1Open filing 0001493152-26-042907 Dispute this row
Kenneth Rickel Common Stock, par value $0.0001 per share5.75,250,000.0008/03/2026 Filed 2026-09-15SCHEDULE 13GOpen filing 0001493152-26-042788 Dispute this row
Gary Stetz Common Stock, par value $0.0001 per share5.75,250,000.0008/03/2026 Filed 2026-08-20SCHEDULE 13DOpen filing 0001493152-26-039482 Dispute this row
Sireesh Appajosyula Common Stock, par value $0.0001 per share5.75,250,000.0008/03/2026 Filed 2026-08-20SCHEDULE 13DOpen filing 0001493152-26-039483 Dispute this row
Gravitas Capital LP Common Stock, par value $0.0001 per share21.421,000,000.0008/03/2026 Filed 2026-08-20SCHEDULE 13D/AAmendment 1Open filing 0001493152-26-039484 Dispute this row
Invictus Capital Advisors Pension Plan Common Stock, par value $0.0001 per share5.75,250,000.0008/03/2026 Filed 2026-08-20SCHEDULE 13D/AAmendment 1Open filing 0001493152-26-039484 Dispute this row
Vincent LoPriore Common Stock, par value $0.0001 per share26.226,250,000.0008/03/2026 Filed 2026-08-20SCHEDULE 13D/AAmendment 1Open filing 0001493152-26-039484 Dispute this row
Black Global 5 LLC Common Stock, par value $0.0001 per share11.110,000,000.0007/31/2026 Filed 2026-08-07SCHEDULE 13DOpen filing 0002146838-26-000001 Dispute this row
Red Global 3, LLC Common Stock, par value $0.0001 per share11.110,000,000.0007/31/2026 Filed 2026-08-07SCHEDULE 13DOpen filing 0002146838-26-000001 Dispute this row
Darin Feinstein Common Stock, par value $0.0001 per share11.110,000,000.0007/31/2026 Filed 2026-08-07SCHEDULE 13DOpen filing 0002146838-26-000001 Dispute this row
Gravitas Capital LP Common Stock, par value $0.0001 per share17.175,000,000.0004/21/2026 Filed 2026-05-01SCHEDULE 13DOpen filing 0001493152-26-020941 Dispute this row
Invictus Capital Advisors Pension Plan Common Stock, par value $0.0001 per share4.291,250,000.0004/21/2026 Filed 2026-05-01SCHEDULE 13DOpen filing 0001493152-26-020941 Dispute this row
Vincent LoPriore Common Stock, par value $0.0001 per share21.466,250,000.0004/21/2026 Filed 2026-05-01SCHEDULE 13DOpen filing 0001493152-26-020941 Dispute this row
S.H.N. Financial Investments Ltd. Common Stock, par value $0.0001 per share00.0008/14/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001079973-25-001303 Dispute this row
Anson Funds Management LP Common Stock, par value $0.0001 per share4.9576,48206/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000950170-25-109202 Dispute this row
Anson Management GP LLC Common Stock, par value $0.0001 per share4.9576,48206/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000950170-25-109202 Dispute this row
Tony Moore Common Stock, par value $0.0001 per share4.9576,48206/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000950170-25-109202 Dispute this row
Anson Advisors Inc. Common Stock, par value $0.0001 per share4.9576,48206/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000950170-25-109202 Dispute this row
Amin Nathoo Common Stock, par value $0.0001 per share4.9576,48206/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000950170-25-109202 Dispute this row
Moez Kassam Common Stock, par value $0.0001 per share4.9576,48206/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000950170-25-109202 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,700,931 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015117,313
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to HEPION PHARMACEUTICALS, INC.